You are viewing the site in preview mode

Skip to main content

Table 1 Age-standardized prevalence and disabling impact of chronic conditions by educational level and gender, the Disability-Health survey, France, 2008–2009 (N = 23,348 respondents 25 years and older)

From: Contribution of chronic diseases to educational disparity in disability in France: results from the cross-sectional “disability-health” survey

  Primary Secondary Tertiary
Prevalencea,
% (95% CI)
Disabling impactb, mean (95% CI) Prevalencea,
% (95% CI)
Disabling impactb, mean (95% CI) Prevalencea,
% (95% CI)
Disabling impactb, (mean, 95% CI)
Men
 Spine disorders 21.35 (20.23–22.52) 0.28 (0.19–0.36) 18.47 (17.46–19.53) 0.18 (0.13–0.23) 15.78 (14.14–17.57) 0.15 (0.09–0.21)
 Arthritis 21.05 (19.99–22.15) 0.46 (0.35–0.57) 17.71 (16.67–18.79) 0.53 (0.42–0.63) 11.99 (10.53–13.62) 0.38 (0.24–0.52)
 Dementia 1.51 (1.29–1.75) 0.89 (0.25–1.53) 1.55 (1.23–1.96) 0.62 (−0.01–1.25) 1.30 (0.87–1.95) 3.28 (− 0.56–7.12)
 Stroke 2.61 (2.31–2.95) 0.85 (0.37–1.32) 2.46 (2.12–2.86) 0.76 (0.34–1.17) 1.79 (1.32–2.43) 0.41 (− 0.07–0.89)
 Other neurologic diseases 2.15 (1.88–2.45) 0.99 (0.47–1.50) 2.04 (1.76–2.36) 1.08 (0.61–1.55) 1.32 (1.02–1.70) 0.47 (0.10–0.85)
 Ischemic heart diseases/PAD 9.93 (9.22–10.69) 0.83 (0.62–1.05) 9.37 (8.56–10.26) 0.57 (0.38–0.76) 6.05 (4.99–7.32) 0.64 (0.32–0.96)
 Other heart diseases 6.28 (5.75–6.85) 0.61 (0.33–0.88) 6.38 (5.74–7.07) 0.29 (0.11–0.46) 5.65 (4.54–7.01) 0.31 (0.09–0.53)
 COPD 10.10 (9.37–10.89) 0.42 (0.27–0.57) 7.67 (6.98–8.43) 0.28 (0.17–0.38) 5.51 (4.55–6.65) 0.14 (0.02–0.26)
 Psychiatric diseases 7.79 (7.18–8.45) 0.65 (0.43–0.87) 4.85 (4.42–5.33) 0.54 (0.38–0.71) 5.02 (4.24–5.92) 0.36 (0.17–0.54)
 Sensorial diseases 0.96 (0.76–1.20) 0.46 (−0.03–0.96) 1.49 (1.15–1.92) 0.18 (−0.11–0.47) 0.45 (0.29–0.71) 0.09 (− 0.19–0.38)
 Cancer 3.37 (2.97–3.82) 0.66 (0.37–0.95) 3.11 (2.64–3.66) 0.38 (0.15–0.61) 1.92 (1.45–2.56) 0.49 (0.12–0.85)
 Diabetes 10.69 (9.95–11.47) 0.20 (0.09–0.31) 7.23 (6.56–7.97) 0.13 (0.04–0.23) 5.15 (4.28–6.18) 0.16 (0.01–0.30)
 Accidents 5.37 (4.84–5.94) 0.96 (0.62–1.29) 4.59 (4.16–5.07) 0.61 (0.44–0.78) 3.29 (2.64–4.10) 0.45 (0.22–0.69)
Women
 Spine disorders 23.00 (22.10–23.93) 0.33 (0.25–0.41) 23.08 (21.99–24.21) 0.30 (0.24–0.35) 22.32 (20.54–24.21) 0.13 (0.08–0.18)
 Arthritis 29.95 (28.95–30.97) 0.55 (0.47–0.64) 23.77 (22.65–24.93) 0.43 (0.36–0.51) 21.03 (19.14–23.06) 0.34 (0.23–0.45)
 Dementia 1.31 (1.16–1.47) 1.44 (0.79–2.09) 0.82 (0.65–1.04) 1.22 (0.24–2.20) 0.53 (0.29–0.96) 3.00 (−3.34–9.35)
 Stroke 1.91 (1.72–2.13) 0.79 (0.35–1.22) 1.37 (1.12–1.68) 1.76 (0.72–2.80) 1.74 (1.22–2.46) 1.15 (0.07–2.23)
 Other neurologic diseases 2.12 (1.88–2.39) 1.23 (0.66–1.79) 1.45 (1.25–1.69) 1.20 (0.67–1.72) 1.66 (1.31–2.10) 0.79 (0.35–1.23)
 Ischemic heart diseases/PAD 3.74 (3.45–4.06) 0.94 (0.61–1.27) 3.22 (2.78–3.73) 0.80 (0.41–1.20) 3.44 (2.49–4.75) 0.34 (−0.16–0.83)
 Other heart diseases 6.16 (5.74–6.59) 0.75 (0.53–0.97) 4.82 (4.32–5.37) 0.34 (0.15–0.53) 6.94 (5.64–8.51) 0.48 (0.16–0.81)
 COPD 8.15 (7.61–8.71) 0.22 (0.10–0.33) 7.44 (6.81–8.12) 0.35 (0.25–0.45) 7.36 (6.20–8.72) 0.35 (0.22–0.48)
 Psychiatric diseases 12.92 (12.25–13.61) 0.44 (0.32–0.57) 9.09 (8.49–9.73) 0.34 (0.24–0.44) 7.90 (6.92–9.00) 0.23 (0.11–0.34)
 Sensorial diseases 0.56 (0.45–0.69) 1.14 (0.31–1.96) 0.39 (0.29–0.52) 0.84 (0.04–1.64) 0.65 (0.43–0.99) 0.50 (−0.27–1.28)
 Cancer 2.98 (2.65–3.35) 0.90 (0.59–1.22) 2.49 (2.15–2.88) 1.08 (0.72–1.44) 3.72 (2.83–4.86) 1.46 (0.82–2.10)
 Diabetes 8.43 (7.94–8.95) 0.38 (0.25–0.51) 4.79 (4.28–5.34) 0.29 (0.15–0.44) 2.19 (1.64–2.93) 0.43 (0.03–0.83)
 Accidents 3.22 (2.89–3.60) 0.28 (0.06–0.50) 3.30 (2.92–3.73) 0.53 (0.31–0.74) 3.85 (3.12–4.74) 0.93 (0.56–1.31)
  1. CI Confidence interval; Prevalence rates are weighted and age-standardized to the French population of men and women estimated by the 2009 census (French National Institute of Statistics and Economic Studies). The disabling impact is the disease-specific cumulative rates of disability for each disease (that is the β in the linear predictor presented in formula (1)). Spine disorders (low back pain, neck pain, spine deformity), arthritis (rheumatoid arthritis, other type of inflammatory arthritis, osteoarthritis), Parkinson and Alzheimer diseases (and other types of dementia), neurologic diseases (epilepsy, multiple sclerosis), stroke, ischemic heart disease/peripheral artery disease (PAD), other heart diseases (arrhythmia, heart failure), chronic obstructive pulmonary diseases (COPD) (asthma, chronic bronchitis), psychiatric diseases (anxiety, depression, schizophrenia and autism), sensorial diseases (blindness or severe visually impairment, deafness or serious hearing loss), cancer, diabetes, and sequelae of injury